Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Buy Rating on Amgen (AMGN)

October 15, 2024 2:20 PM
TD Cowen analyst Yaron Werber reiterated a Buy rating and $381.00 price target on Amgen (NASDAQ: AMGN).The analyst commented, "Uplizna ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles